TURQUOISE regimen active against HCV-HIV coinfection

WASHINGTON – Early studies show that a new, combined antiviral regimen seems to suppress hepatitis C viremia while keeping HIV viremia stable in coinfected patients. Dr. Joseph Eron presented phase...

Field of Interest: Gastroentero...
Type: News Item

Studies point to potential for huge HCV rise in MSM

WASHINGTON – Two studies of men having sex with men suggest that hepatitis C transmission in that group might be on the cusp of a big increase, in part because of risky behavior such as unprotected...

Field of Interest: Gastroentero...
Type: News Item

IBS symptoms improve after fecal transplant

Fecal microbiota transplant improved or alleviated symptoms in 70% of patients with refractory irritable bowel syndrome, a small retrospective study has determined. A single transfusion of fresh...

Field of Interest: Gastroentero...
Type: News Item

FDA approves oritavancin for skin infections

The Food and Drug Administration has approved the injectable antibiotic oritavancin (Orbactiv) to treat adults with acute bacterial skin and skin structure infections that might be caused by...

Field of Interest: Dermatology
Type: News Item

Simulation model projects HCV to be rare by 2026

A simulation model that incorporated a one-time universal screening of U.S. adults for hepatitis C virus and made conservative assumptions as to the availability and efficacy of various therapies...

Field of Interest: Gastroentero...
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness